CellMetrix, Inc. is a medical technology company with limited business operations. The Company planned to fully develop laboratory systems that provide highly sensitive testing capabilities through automated screening technology. It is also planned to develop numerous clinical applications that test for cancer or other serious medical conditions. The Company's first clinical application, LungCheck, was targeted at healthcare providers that treat people at risk for lung disease. The LungCheck test would be fully leveraged through integration with technology provided by AccuMed International, Inc. through the Patent and Technology License and Registration Rights Agreement.